Switch to Systemic Oral Antibiotics
When topical mupirocin fails to resolve a big toe infection, the next step is to initiate systemic oral antibiotic therapy with coverage for both Staphylococcus aureus and Streptococcus species. 1
Why Topical Therapy Has Failed
The FDA label for mupirocin explicitly states that patients not showing clinical response within 3 to 5 days should be re-evaluated 1. Topical mupirocin is designed for superficial skin infections, and failure suggests either:
- Deeper tissue involvement beyond what topical agents can penetrate
- Mupirocin resistance (increasingly common with S. aureus, reported as high as 81% in some settings) 2, 3
- Wrong pathogen (fungal infection, resistant bacteria, or polymicrobial infection)
- Underlying structural problem (foreign body, abscess requiring drainage, osteomyelitis)
Immediate Next Steps
1. Obtain Cultures Before Starting Antibiotics
- Swab or aspirate the infected area for culture and sensitivity
- Blood cultures if systemic signs present (fever, chills, spreading erythema)
- This is critical given rising mupirocin resistance 4, 2
2. Assess Severity and Choose Antibiotic Route
For mild infection without systemic signs:
- Oral antibiotics targeting MSSA and Streptococcus
- Options include:
- Cephalexin (first-line for most community-acquired infections)
- Dicloxacillin
- Amoxicillin-clavulanate 5
For moderate infection with systemic signs OR risk factors for MRSA: Risk factors include: penetrating trauma, injection drug use, known MRSA colonization, purulent drainage, or previous MRSA infection 4
- Oral options:
For severe infection with SIRS or concern for deeper infection:
3. Rule Out Alternative Diagnoses
Fungal infection (tinea pedis):
- The big toe location raises concern for fungal infection, especially if there's scaling, maceration, or involvement of interdigital spaces 4, 6
- If fungal infection suspected: obtain KOH prep and fungal culture
- Treatment would require oral antifungals (terbinafine or itraconazole) rather than antibiotics 6, 7
Abscess or purulent collection:
- If fluctuance present, incision and drainage is the primary treatment, not antibiotics alone 4
- The guideline explicitly states that purulent collections require drainage as the major component of management 4
4. Address Predisposing Factors
Critical for preventing recurrence 4:
- Examine interdigital toe spaces for fissuring, scaling, or maceration—treating these reduces pathogen colonization and recurrence risk 4
- Elevate the affected foot 4
- Treat underlying conditions: edema, venous insufficiency, diabetes, tinea pedis 4
- Ensure proper foot hygiene and footwear
Treatment Duration
- Minimum 5 days of oral antibiotics, but extend if not improved within this timeframe 4
- Typical course is 7-10 days for uncomplicated skin infections
Common Pitfalls to Avoid
- Continuing topical therapy beyond 3-5 days without response is inappropriate per FDA guidance 1
- Missing an abscess that requires drainage—antibiotics alone will fail 4
- Not considering fungal infection in toe/foot infections, especially with chronic or recurrent presentation 6
- Using trimethoprim-sulfamethoxazole alone when Streptococcus coverage is needed 5
- Ignoring interdigital toe space examination—untreated tinea pedis or maceration perpetuates bacterial colonization 4
When to Hospitalize
Admit if any of the following are present 4:
- Systemic inflammatory response syndrome (SIRS)
- Hemodynamic instability
- Altered mental status
- Concern for necrotizing infection or deeper involvement (osteomyelitis, septic arthritis)
- Severe immunocompromise
- Poor adherence anticipated with outpatient therapy